This panel seeks to address the pathways for federal cannabis reform in the 117th
Congress, considering legislative vehicles, political pragmatism, and actions of the
Administration.
Interstate commerce continues to be at the forefront of the industry's collective mind as we look for solutions to incongruence of supply and demand, stalled equity programs, and fierce competition between and among both licensed participants and illicit businesses.
This panel will discuss the most relevant issues within this area and the best practices applied by leading practitioners in this field. The panel will provide an overview of financing opportunities and methods, timing for investments and other financing vehicles, and positioning your clients for responsible growth.
Navigating the Highs and Lows of Cannabis Regulatory Compliance—Insights, Best Practices, and Hurdles. Examine regulatory compliance “hot topics”, including maintaining state licenses and navigating enforcement actions, and explore best practices for corporate governance, novel partnership agreements such as IP licensing and white labeling, and regulatory considerations of various exit strategies for mature cannabis enterprises.
Attendees will gain an overview of the UK Cannabis markets, including an overview of the small but growing medical segment, as well as the booming CBD and wellness industries.
Take a look at how to shore up those international supply chain needs, the potential of interstate commerce under state-implemented Memoranda of Understanding, and the future of supply chain consistency in a post-legalized world.